Global health security news, resources and funding for global health researchers

Fogarty and NIH are committed to improving global health security by building the capacity of countries to address public health threats, health emergencies and infectious disease outbreaks.

Scientists world-wide must work together to stop epidemics early and at the source. Programs supported by Fogarty develop infectious disease research capacity, provide training in countries with little or no infrastructure, and link scientists to a global network of experts. The training provided to health care workers, doctors and researchers requires a relatively modest investment, but could provide the tools countries need to halt disease outbreaks in their tracks, possibly preventing the need for large-scale emergency efforts like the ones assembled to fight recent Ebola and Zika virus outbreaks.

The National Institute of Allergy and Infectious Diseases (NIAID) leads NIH infectious disease research, included research related to biodefense and emerging infectious diseases.

Recent News

• Coronavirus news, funding and resources for global health researchers compiled by Fogarty
• NIH-sponsored trial data offer further evidence to help inform mpox treatment decisions
  NIAID News, March 17, 2025
  
• NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain
  NIAID News, December 10, 2024
• Fatal Oropouche Virus Infections in Nonendemic Region, Brazil, 2024
  Emerging Infectious Diseases, September 13, 2024
• NIH releases mpox research agenda
  NIH/NIAID news, September 17, 2024
• NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry
  NIH/NCI news, September 16, 2024
• NIH awards establish pandemic preparedness research network
  NIH/NIAID news, September 13, 2024
• Progress Toward Poliomyelitis Eradication — Pakistan, January 2023–June 2024
  CDC Morbidity and Mortality Weekly Report (MMWR), September 12, 2024
• Oropouche Virus Disease Among U.S. Travelers — United States, 2024
  CDC Morbidity and Mortality Weekly Report (MMWR), September 5, 2024
• Contact Tracing for Mpox Clade II Cases Associated with Air Travel — United States, July 2021–August 2022
  CDC Morbidity and Mortality Weekly Report (MMWR), September 5, 2024
  
• 2023 Outbreak in Democratic Republic of the Congo
  CDC outbreak news, August 15, 2024
• The antiviral tecovirimat is safe but did not improve clade I mpox resolution in Democratic Republic of the Congo
  NIH/NIAID news, August 15, 2024
• United States Government’s Response to the Clade I Mpox Outbreak in the Democratic Republic of the Congo and Other Countries in the Region
  U.S. Department of Health and Human Services news, August 14, 2024

Fogarty Grant Recipient & Trainee Publications

• Editorial: A call for global solidarity and rapid action to control mpox, co-authored by Fogarty grant recipients Jean B. Nachega and  Jean‑Jacques Muyembe‑Tamfum
  The Lancet, September 9, 2024
• Perspective: Mpox in Pregnancy — Risks, Vertical Transmission, Prevention, and Treatment, co-authored by Fogarty grant recipients Jean Nachega, Jean-Jacques Muyembe-Tamfum, and Landon Meyer
  New England Journal of Medicine, August 28, 2024
  
• Detection of mobile colistin resistance genes mcr-9.1 and mcr-10.1 in Enterobacter asburiae from Ecuadorian children, co-authored by Fogarty Global Health Fellow Sara G. Cifuentes
  Microbiology Resource Announcements, August 20, 2024
• Differentiated Service Delivery Models for Maintaining HIV Treatment and Prevention Services During Crisis and Disease Outbreaks: Lessons from the COVID-19 Pandemic, co-authored by former Fogarty trainees Njambi Njuguna, Jared M. Baeten 5, and Nelly R. Mugo
  Current HIV/AIDS Reports, July 25, 2025
• Risk of arboviral transmission and insecticide resistance status of Aedes mosquitoes during a yellow fever outbreak in Ghana, co-authored by Fogarty grant recipient Yaw Asare Afrane
  BMC Infectious Diseases, July 25, 2025

NIH News and Resources

• National Institute of Allergy and Infectious Diseases (NIAID) on biodefense and emerging infectious diseases
• NIH Public Health Emergency and Disaster Research Response (DR2) - a pilot program developed by the National Institute of Environmental Health Sciences (NIEHS) in collaboration with the National Library of Medicine (NLM)

Other US Government Resources

• White House
• United States Global Health Security Strategy 2024 [PDF], published April 2024
• National Biodefense Strategy and Implementation Plan for Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Security [PDF], published October 2022
• Department of Health and Human Services
  
• About the Global Health Security Agenda from HHS
• Global Health Security Agenda, a partnership of nations, international organizations and non-governmental stakeholders
• Public health emergency information from the HHS Assistant Secretary for Preparedness and Response
• Centers for Disease Control and Prevention (CDC)
• CDC and the Global Health Security Agenda
• Emerging Infectious Diseases from CDC
• National Center for Emerging and Zoonotic Infectious Diseases at CDC
• Office of Public Health Preparedness and Response at CDC
• Department of Homeland Security National Biodefense Analysis and Countermeasures Center
• Department of State information on International Health and Biodefense
• Federal Emergency Management Agency (FEMA) Ready.gov
  

Other Online Resources

• Coalition for Epidemic Preparedness Innovations (CEPI)
  
• World Health Organization (WHO):
• Emergency and disaster risk management for health
  
• Strengthening health security by implementing the International Health Regulations (IHR)
  

Updated March 18, 2025